Combined 70- and 80-gene signatures identify tumors with genomically luminal biology responsive to neoadjuvant endocrine therapy and are prognostic of 5-year outcome in early-stage breast cancer
Pellicane, James V., Beitsch, Peter D., Rock, David T., Budway, Raye J., Dul, Carrie L., Kelemen, Pond R., Ashikari, Andrew Y., Baron, Paul L., Weinstein, Paul D., Mislowsky, Angela, Lee, Laura A., Beatty, Jennifer, Murray, Mary K., Dupree, Beth B., Finn, Christine, Corcoran, Kate, Wang, Shiyu, Menicucci, Andrea R., Yoder, Erin B., Blumencranz, Lisa E., Dauer, Patricia, Audeh, William, Whitworth, Pat W.
Published in Surgical oncology (01.12.2022)
Published in Surgical oncology (01.12.2022)
Get full text
Journal Article